132 related articles for article (PubMed ID: 8551729)
1. Clinical significance of cathepsin D assay in breast cancer tissues.
Itoh Y; Kobayashi S; Iwase H; Yamashita H; Kuzushima T; Iwata H; Yamashita T; Naitoh A; Itoh K; Masaoka A
J Surg Oncol; 1995 Dec; 60(4):221-6. PubMed ID: 8551729
[TBL] [Abstract][Full Text] [Related]
2. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer.
Iwase H; Itoh Y; Kuzushima T; Yamashita H; Iwata H; Toyama T; Hara Y; Kobayashi S
Cancer Detect Prev; 1997; 21(1):29-35. PubMed ID: 9043760
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study.
Henry JA; McCarthy AL; Angus B; Westley BR; May FE; Nicholson S; Cairns J; Harris AL; Horne CH
Cancer; 1990 Jan; 65(2):265-71. PubMed ID: 2295049
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group.
Fernö M; Baldetorp B; Borg A; Brouillet JP; Olsson H; Rochefort H; Sellberg G; Sigurdsson H; Killander D
Eur J Cancer; 1994; 30A(14):2042-8. PubMed ID: 7857700
[TBL] [Abstract][Full Text] [Related]
6. Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.
Maudelonde T; Khalaf S; Garcia M; Freiss G; Duporte J; Benatia M; Rogier H; Paolucci F; Simony J; Pujol H
Cancer Res; 1988 Jan; 48(2):462-6. PubMed ID: 3275497
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T
Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancers.
Granata G; Coradini D; Cappelletti V; Di Fronzo G
Eur J Cancer; 1991; 27(8):970-2. PubMed ID: 1832905
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.
Lah TT; Cercek M; Blejec A; Kos J; Gorodetsky E; Somers R; Daskal I
Clin Cancer Res; 2000 Feb; 6(2):578-84. PubMed ID: 10690542
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.
Foekens JA; Schmitt M; van Putten WL; Peters HA; Kramer MD; Jänicke F; Klijn JG
J Clin Oncol; 1994 Aug; 12(8):1648-58. PubMed ID: 8040677
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: an immunohistochemical study.
Têtu B; Brisson J; Côté C; Brisson S; Potvin D; Roberge N
Int J Cancer; 1993 Sep; 55(3):429-35. PubMed ID: 8397164
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer.
Castiglioni T; Merino MJ; Elsner B; Lah TT; Sloane BF; Emmert-Buck MR
Hum Pathol; 1994 Sep; 25(9):857-62. PubMed ID: 8088759
[TBL] [Abstract][Full Text] [Related]
13. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer.
Kandalaft PL; Chang KL; Ahn CW; Traweek ST; Mehta P; Battifora H
Cancer; 1993 May; 71(9):2756-63. PubMed ID: 8385566
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP
J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367
[TBL] [Abstract][Full Text] [Related]
16. Relationship between cathepsin-D and other prognostic factors in human breast cancer.
Glikman P; Rogozinski A; Mosto J; Pollina A; Garbovesky C; Levy C
Tumori; 1997; 83(3):685-8. PubMed ID: 9267489
[TBL] [Abstract][Full Text] [Related]
17. [Cathepsin D expression in primary breast cancer. Comparison of immunohistochemical and biochemical results].
Göhring UJ; Ingenhorst A; Crombach G; Scharl A
Pathologe; 1993 Dec; 14(6):313-7. PubMed ID: 8121884
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cathepsin D as prognostic predictor in breast cancer.
Barbi GP; Margallo E; Margiocco M; Paganuzzi M; Marroni P; Costanzi B; Gatteschi B; Tanara G; Spina B; Nicolò G
Oncology; 1994; 51(4):329-33. PubMed ID: 8208515
[TBL] [Abstract][Full Text] [Related]
19. [Cathepsin D in primary breast cancer in correlation with various prognostic factors].
Rempen A; Caffier H
Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):272-5. PubMed ID: 1650323
[TBL] [Abstract][Full Text] [Related]
20. The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer. The South Australian Breast Cancer Study Group.
Seshadri R; Horsfall DJ; Firgaira F; McCaul K; Setlur V; Chalmers AH; Yeo R; Ingram D; Dawkins H; Hahnel R
Int J Cancer; 1994 Jan; 56(1):61-5. PubMed ID: 8262679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
